Results

569.

Türk, M., Yilmaz, I., Bahcecioglu, S. N., Cetin, G. P., Komi, D. E.-A., and Maurer, M.⁺: Capsaicin pretreatment increases mast cell-mediated but not histamine-induced wheal and erythema responses: a proof-of-concept study. Asthma Allergy Immunol. 2024: 22; 49-57. IF: TBD (IF 2023: 0.3)

570.

Zhu, L.^*, Jian, X.^*, Zhou, B.^*, Liu, R.^*, Munoz, M., Sun, W., Xie, L.⁺, Chen, X., Peng, C., Maurer, M.⁺, and Li, J.⁺: Gut microbiota facilitate chronic spontaneous urticaria. Nat. Commun. 2024: 15; 112. IF: TBD (IF 2023: 14.70)

571

Rubeiz, C. J.⁺, Asero, R., Betschel, S., Craig, T., Grumach, A., Hide, M., Lang, D., Levin, M., Longhurst, H., Magan, E., Maurer, M., Saini, S. S., Sussman, G., Toubi, E., Van, D. N., Zuberbier, T., and Bernstein, J. A.: Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria. World Allergy Organ J. 2024: 17; 100858. IF: TBD (IF 2023: 3.90)

572.

Neisinger, S.⁺, Sousa Pinto, B., Ramanauskaite, A., Bousquet, J., Weller, K., Metz, M., Magerl, M., Kocatürk, E., Cherrez-Ojeda, I., Giménez-Arnau, A. M., Parisi, C. A. S., Altrichter, S., Ensina, L. F., Bouillet, L., Asero, R., Goncalo, M., Guillet, C., Rutkowski, K., Bernstein, J. A., Hardin, H., Godse, K., Brzoza, Z., Laco Sousa, J. I., Thomsen, S. F., van Doorn, M., Hide, M., Ye, Y.-M., Vanderse, S., Lapina, L., Peter, J., Zhao, Z., Han, L., Nasr, I., Rockmann-Helmbach, H., Astrup Sørensen, J., Öztas Kara, R., Kurjane, N., Kurchenko, A., Kaidashev, I., Tsaryk, V., Stepanenko, R., and Maurer, M.: CRUSE^® – an innovative mobile application for patient monitoring and management in chronic spontaneous urticaria. Clin. Transl. Allergy 2024: e12328. IF: TBD (IF 2023: 4.60)

573.

Moñino-Romero, S., Kolkhir, P., Ohanyan, T., Szépfalusi, Z., Weller, K., Metz, M., Scheffel, J., Maurer, M.⁺, and Altrichter, S.: Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2024: 38; 167-174. IF: TBD (IF 2023: 8.40)

574.

Weller, K., Giménez-Arnau, A. M., Baron, J., Brehler, R., Ferrer, M., Groffik, A., Grundmann, S., Jakob, T., Labrador-Horrillo, M., Müller, S., Staubach, P., Wurpts, G., Metz, M., and Maurer, M.⁺: Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: a randomized trial. Allergy 2024: 79; 93-103. IF: TBD (IF 2023: 12.60)

576.

Maurer, M.⁺, Lumry, W. R., Li, H. H., Aygören-Pürsün, E., Busse, P. J., Jacobs, J., Nurse, C., Ahmed, M. A., Watt, M., Yu, M., and SPRING Investigators: Lanadelumab in patients 2 to less than 12 years old with hereditary angioedema: results from the phase 3 SPRING study. J. Allergy Clin. Immunol. Pract. 2024: 12; 201-2011. IF: TBD (IF 2023: 8.20)

577.

Mostmans, Y.⁺, Maurer, M., Richert, B., Smith, V., Melsens, K., De Maertelaer, V., Saidi, I., Corazzi, F., and Michel, O.: Chronic spontaneous urticaria: evidence of systemic microcirculatory changes. Clin. Transl. Allergy 2024: 14; e12335. IF: TBD (IF 2023: 4.60)